Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Silk Road Medical Inc (SILK)

Silk Road Medical Inc (SILK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Silk Road Medical Inc 1213 INNSBRUCK DR. SUNNYVALE CA 94089 USA

www.silkroadmed.com Employees: 474 P: 408-720-9002 F: 408-720-9013

Description:

Silk Road Medical Inc. is a medical device company. It is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization. TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Silk Road Medical Inc. is based in Sunnyvale, California.

Key Statistics

Overview:

Market Capitalization, $K 1,084,316
Enterprise Value, $K 1,139,736
Shares Outstanding, K 39,444
Annual Sales, $ 177,130 K
Annual Net Income, $ -55,740 K
Last Quarter Sales, $ 51,240 K
Last Quarter Net Income, $ -16,600 K
EBIT, $ -60,170 K
EBITDA, $ -62,640 K
60-Month Beta 1.53
% of Insider Shareholders 3.90%
Float, K 37,906
% Float 96.10%
Short Volume Ratio 0.60

Growth:

1-Year Return 62.47%
3-Year Return -50.64%
5-Year Return -13.14%
5-Year Revenue Growth 412.53%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.42 on 08/07/24
Next Earnings Date 08/06/24
Earnings Per Share ttm -1.44
EPS Growth vs. Prev Qtr -16.67%
EPS Growth vs. Prev Year -20.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SILK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -37.30%
Return-on-Assets % -21.57%
Profit Margin % -31.47%
Debt/Equity 0.49
Price/Sales 6.31
Price/Cash Flow N/A
Price/Book 7.01
Book Value/Share 3.92
Interest Coverage -7.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar